Abciximab reduces mortality in diabetics following percutaneous coronary intervention - Bhatt, Deepak L; Marso, Steven P; Lincoff, A.Michael; Wolski, Katherine E; Ellis, Stephen G; Topol, Eric J (Journal of the American College of Cardiology, 2000)
Keywords: Abciximab; Adult; Aged; Angina, Unstable - mortality; Angina, Unstable - therapy; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal - adverse effects; Antibodies, Monoclonal - therapeutic use; Biological and medical sciences; Blood. Blood coagulation. Reticuloendothelial system; Diabetic Angiopathies - mortality; Diabetic Angiopathies - therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments - adverse effects; Immunoglobulin Fab Fragments - therapeutic use; Male; Medical sciences; Middle Aged; Myocardial Infarction - mortality; Myocardial Infarction - therapy; Pharmacology. Drug treatments; Platelet Aggregation Inhibitors - adverse effects; Platelet Aggregation Inhibitors - therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stents; Survival Rate; CHF; TVR; EPISTENT; GP IIb/IIIa; EPIC; CI; PCI; CK; MI; EPILOG; BMI; Endocrinopathy; Human; Abciximab; Prognosis; Diabetes mellitus; Mortality; Coronary artery; Instrumentation therapy; Instrumental dilatation; Antiplatelet agent; Chemotherapy; Treatment; Follow up study